News summary
Shanhe Pharmaceutical Co., Ltd. announced that its sodium stearyl fumarate pharmaceutical excipient passed national review and approvalasiangamesjakarta2018, this product is suitable as a lubricant for a variety of tablets and capsules.
Newsletter text
Shanhe Pharmaceutical Aid: Successfully passed the CDE reviewasiangamesjakarta2018sodium stearyl fumarate
Shanhe Pharmaceutical Co., Ltd. recently announced that the sodium stearyl fumarate pharmaceutical excipient it submitted has successfully passed the joint review and approval of the Drug Evaluation Center of the State Food and Drug Administration and the preparation. This excipient is mainly used for lubrication of tablets and capsules, is compatible with most active pharmaceutical ingredients (APIs), and is considered an ideal alternative to magnesium stearate.
This achievement marks that Shanhe Pharmaceutical Co., Ltd. has been officially recognized for its technical strength in the field of pharmaceutical excipients and is expected to gain advantages in subsequent market promotion. The launch of sodium stearyl fumarate also heralds the addition of a new member to the pharmaceutical excipient industry, providing more options for pharmaceutical companies.
This development by Shanhe Pharmaceutical Co., Ltd. is a positive signal for secondary market investors, indicating that the company is committed to R & D and innovation to enhance its market competitiveness.